Adverse Events of DOACs in Children

Venous thromboembolism (VTE) has an increasing rate of significance in pediatric patients. The currently standardized anticoagulants (unfractionated heparin, low molecular weight heparin and vitamin K antagonists) and their dose regimens were not comprehensively trialed in pediatric patients. Recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosch, Alessandra, Albisetti, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289097/
https://www.ncbi.nlm.nih.gov/pubmed/35859947
http://dx.doi.org/10.3389/fped.2022.932085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289097/
https://www.ncbi.nlm.nih.gov/pubmed/35859947
http://dx.doi.org/10.3389/fped.2022.932085

Ejemplares similares